Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI vs. doctors: the race to spot lung cancer earlier

NCT ID NCT07280559

Summary

This study is testing whether artificial intelligence (AI) software can help doctors read low-dose CT scans more accurately during lung cancer screening. About 1,120 adults at risk for lung cancer will be randomly assigned to have their scans read either with AI assistance or by doctors using standard methods. The goal is to see if AI helps find cancers earlier, reduces false alarms, and improves patient outcomes like survival rates.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Taipei Veterans General Hospital

    Taipei, Taiwan, 112, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.